Jun 23, 2026
17 MIN READ

How Long Does Wegovy Take to Start Working? Your Timeline for Weight Loss

Semaglutide typically reduces appetite within days, but meaningful weight loss appears around weeks 4–8 of treatment. PlexusDx breaks down the realistic timeline for compounded semaglutide injections and what happens at each stage.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 23, 2026
17 MIN READ

how long does wegovy take to start working? your timeline for weight loss — PlexusDx GLP-1 education

Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Most people taking semaglutide notice changes in how they feel around food within the first 1–2 weeks, though the scale may not shift immediately. Clinical trials show that participants averaged 5–10% body weight loss by week 12, with continued progress over 6 months. Understanding what to expect at each stage helps you stay motivated and assess whether treatment is working for your body.

Week 1–2: Appetite Suppression Begins

The earliest sign of semaglutide working is a change in appetite, often described as a sudden lack of interest in food or smaller portion sizes. This happens because semaglutide activates GLP-1 receptors in your brain that control hunger signals and satiety. Many people report feeling fuller after just a few bites and losing cravings for foods they previously enjoyed.

Physical sensations may also appear in the first two weeks: mild nausea, a slight change in digestion, or a metallic taste are common starting effects. These initial responses don't mean the medication is harmful—they're signs your body is adjusting to a new neurological stimulus. Most people find these sensations manageable and temporary, especially if they eat smaller, protein-forward meals.

Week 3–4: Metabolic Shift and Early Weight Changes

By week 3, your metabolism begins to shift as semaglutide influences how your body processes glucose and stores fat. Energy expenditure may increase slightly, meaning you burn more calories at rest than before treatment. Some individuals notice their clothes fit differently or see a 2–4 pound drop on the scale, though others see minimal change this early.

This phase is critical for habit formation: reduced appetite makes it easier to stick to smaller portions and skip snacking. PlexusDx patients often report that behavioral changes feel effortless during this window, not because of willpower but because hunger itself has diminished. Consistency with dosing and eating patterns during weeks 3–4 sets up stronger momentum for months 2–3.

Month 2–3: Consistent Weight Loss and Plateau Awareness

Weeks 8–12 mark the period when clinical trials documented the most noticeable weight loss patterns. Most people lose 1–2 pounds per week during this phase, with cumulative losses reaching 8–15 pounds by the end of week 12. This timeline assumes consistent dosing, appropriate calorie intake, and no major dietary backsliding.

Some individuals hit a temporary plateau around week 6–8, where weight loss slows or pauses for 1–3 weeks. This is a normal metabolic adaptation, not a sign that semaglutide has stopped working. Plateaus typically resolve with continued medication adherence, slight calorie adjustments, or increased movement. PlexusDx providers can help troubleshoot during plateau periods with protocol adjustments or the addition of genetic insights from the Precision Peptide Genetic Test to optimize your peptide response.

Month 4–6: Sustained Results and Dose Optimization

By month 4, cumulative weight loss often reaches 15–25 pounds, and many people reach a new baseline where hunger remains suppressed but no longer dramatic. Your body has adapted to semaglutide's effects, and you've likely built healthier eating habits that feel automatic rather than restrictive. Continued weight loss occurs at a slower pace—typically 0.5–1 pound per week—but the trend remains downward.

Some patients benefit from dose adjustments during this phase to maintain the appetite-suppressing effect without increasing side effects. PlexusDx's dosing structure means your cost stays flat—semaglutide injections start at $149/month whether you're at a starter dose or an optimized dose. This ensures you can work with your provider to find the right therapeutic level without financial barriers to personalized care.

Factors That Affect Your Individual Timeline

Your personal timeline depends on starting weight, metabolic health, diet quality, exercise level, genetics, and medication adherence. People with higher starting weights often see faster initial losses, while those with insulin resistance may see a slower response initially. Age, hormonal factors, and prior weight loss attempts also influence how quickly semaglutide reshapes your appetite and metabolism.

The Precision Peptide Genetic Test from PlexusDx identifies how your genetic variants in GLP1R, GIPR, FTO, and MC4R genes may influence your response to semaglutide. This $99 add-on test, taken after your first month of treatment, maps 14 metabolic pathways and 150+ genetic insights to help your provider personalize your protocol for faster, more predictable results. Genetic data can explain why one person loses 12 pounds in month 1 while another loses 4—it's not willpower, it's biology.

Setting Realistic Expectations for Your Weight Loss Journey

Semaglutide is not an overnight fix: real, sustained weight loss unfolds over weeks and months, not days. The FDA-studied GLP-1 agonists showed an average weight loss of 13–22% of baseline body weight over 68 weeks in clinical trials, but individual results vary widely. Expecting 2–3 pounds per week initially and 0.5–1 pound per week after month 3 is a realistic framework.

PlexusDx compounded semaglutide injections (starting at $149/month) offer the same active ingredient as brand Wegovy but at a fraction of the price and with access across all 50 states—no insurance or membership fees required. Your dose may need to go up to reach your target appetite suppression level, but your price won't. This commitment to flat pricing means you can focus on your health timeline, not your wallet.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How long before semaglutide shows up on the scale?

Most people see their first 1–3 pound weight change between weeks 2–4, though some don't see scale movement until week 6–8. Appetite suppression happens much faster—often within days—even if weight loss is delayed. Consistency with dosing and eating habits during the first month sets up the foundation for visible results by week 8.

Why doesn't weight loss happen in the first week?

Weight loss requires a sustained caloric deficit over time; appetite suppression alone doesn't create overnight fat loss. The first week focuses on appetite changes and metabolic signaling. By week 3–4, when smaller portions and reduced cravings compound into a true caloric deficit, the scale begins to shift more noticeably.

Can I start seeing results faster with a higher dose?

Higher doses don't speed up the timeline significantly; they often just increase side effects. Clinical trials used gradual dose escalation over weeks to allow your body to adapt. PlexusDx follows evidence-based protocols and works with you on a timeline that balances efficacy and tolerability—your dose adjusts, but your price stays at $149/month for semaglutide injections.

What if I'm not losing weight by week 8?

A lack of weight loss by week 8 may indicate insufficient appetite suppression (requiring dose adjustment), calorie intake that's too high, or an underlying metabolic issue like insulin resistance. PlexusDx can explore whether the Precision Peptide Genetic Test reveals variant patterns in your GLP1R or GIPR genes that suggest alternative peptide protocols, such as tirzepatide or a dual-compound approach.

Does the Precision Peptide Genetic Test help predict my timeline?

Yes. Variants in GLP1R rs6923761, GIPR rs1800437, and other pathways influence how strongly your body responds to semaglutide and how quickly you'll see appetite suppression and weight loss. PlexusDx's $99 genetic test identifies your 150+ insights and allows your provider to predict your likely response pattern and adjust your protocol proactively rather than waiting and guessing.

Is compounded semaglutide from PlexusDx as fast-acting as brand Wegovy?

Yes. PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies, which produce the identical GLP-1 agonist molecule as brand Wegovy. Timeline and efficacy are equivalent; the difference is cost (starting at $149/month) and availability nationwide without insurance.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves